In advanced breast carcinomas, the a6b4 integrin is associated with a migratory and invasive phenotype. In our current study, we show that expression of the a6b4 integrin in MDA-MB-435 breast carcinoma cells leads to increased expression of the autocrine motility factor autotaxin, as determined by Affymetrix gene chip, realtime quantitative RT-PCR and immunoblot analyses. We further demonstrate that increased autotaxin secretion from integrin a6b4 expressing cells acts to enhance chemotaxis through its ability to convert lysophosphatidylcholine (LPC) to lysophosphatidic acid (LPA) and accounts for 80% of the motogenic activity of the conditioned medium. We determine that integrin a6b4-dependent overexpression of autotaxin in MDA-MB-435 cells is mediated by NFAT1, but not NFAT5, through the use of siRNAs that specifically target autotaxin, integrin b4, NFAT1 and NFAT5. Finally, we show by electrophoretic mobility shift assays that two consensus NFAT binding sites found in the autotaxin promoter strongly and specifically bind NFAT1 from integrin a6b4 expressing cells. In summary, we find that the a6b4 integrin potentiates autotaxin expression through the upregulation and activation of NFAT1. These observations highlight for the first time a mechanism by which NFAT transcription factors can facilitate an invasive and motile phenotype downstream of integrin a6b4 signaling.
In advanced breast carcinomas, the a6b4 integrin is associated with a migratory and invasive phenotype. In our current study, we show that expression of the a6b4 integrin in MDA-MB-435 breast carcinoma cells leads to increased expression of the autocrine motility factor autotaxin, as determined by Affymetrix gene chip, realtime quantitative RT-PCR and immunoblot analyses. We further demonstrate that increased autotaxin secretion from integrin a6b4 expressing cells acts to enhance chemotaxis through its ability to convert lysophosphatidylcholine (LPC) to lysophosphatidic acid (LPA) and accounts for 80% of the motogenic activity of the conditioned medium. We determine that integrin a6b4-dependent overexpression of autotaxin in MDA-MB-435 cells is mediated by NFAT1, but not NFAT5, through the use of siRNAs that specifically target autotaxin, integrin b4, NFAT1 and NFAT5. Finally, we show by electrophoretic mobility shift assays that two consensus NFAT binding sites found in the autotaxin promoter strongly and specifically bind NFAT1 from integrin a6b4 expressing cells. In summary, we find that the a6b4 integrin potentiates autotaxin expression through the upregulation and activation of NFAT1. These observations highlight for the first time a mechanism by which NFAT transcription factors can facilitate an invasive and motile phenotype downstream of integrin a6b4 signaling. Expression of the a6b4 integrin is a defining characteristic of normal epithelial cells, where it nucleates formation of hemidesmosomes that link the cytokeratin cytoskeleton to the basement membrane. In carcinomas, the a6b4 integrin is released from hemidesmosomes, binds the actin cytoskeleton (Rabinovitz et al., 1999) , and is associated with a highly invasive and motile phenotype (Mercurio and Rabinovitz, 2001 ). In breast carcinomas, increased expression of the a6b4 integrin is a poor prognostic factor (Friedrichs et al., 1995; Tagliabue et al., 1998) and is associated with tumor invasion (Jones et al., 1997; Shaw et al., 1997) and metastasis (Mukhopadhyay et al., 1999) . Notably, exogenous expression of this integrin in b4-deficient MDA-MB-435 breast carcinoma cells dramatically increased the ability of these cells to invade a reconstituted basement membrane (Matrigel) (Shaw et al., 1997) and chemotax (O'Connor et al., 1998) . Studies on signaling pathways enhanced by a6b4 have revealed that this integrin promotes the signaling from several proinvasive molecules. Among these molecules are NFAT (Jauliac et al., 2002) and NFkB (Mainiero et al., 2003; Zahir et al., 2003) transcription factors.
The ability of the a6b4 integrin to signal to transcriptional regulators such as NFAT and NFkB suggests that the a6b4 integrin could regulate the expression of genes that can promote a motile and invasive phenotype. To test this hypothesis, we performed Affymetrix gene chip analysis on several clones of MDA-MB-435 cells that were either mock transfected or stably transfected with the b4 integrin, described previously (Shaw et al., 1997) . We find that several hundred genes and ESTs are regulated by integrin a6b4 expression by more than twofold (95% confidence level). Of these genes, autotaxin, a gene associated with breast cancer metastasis, is upregulated 10-to 20-fold (data not shown).
Autotaxin is associated with breast cancer metastasis (Yang et al., 2002) and is a potent motogen (Stracke et al., 1992) . Autotaxin is the second member of the exonucleotide pyrophosphatase and phosphodiesterase family (ENPP2) that was recently found to have lysophospholipase D (lyso-PLD) activity, which leads to the generation of lysophosphatidic acid (LPA) from lysophosphatidylcholine (LPC) (Tokumura et al., 2002; Umezu-Goto et al., 2002) . The ability of autotaxin to generate LPA, which is a known stimulator of breast cancer cell motility and survival (Mills and Moolenaar, 2003) , appears to be critical for autotaxin's role as a motogen and a chemoattractant (Umezu-Goto et al., 2002) . Autotaxin is a secreted protein that is expressed initially as a transmembrane protein, which is then proteolytically cleaved at amino acid 12 by an unknown protease (Clair et al., 1997) and is released into the extracellular milieux.
To validate the results from our gene chip analysis, we performed quantitative real-time PCR (Q-PCR) on total RNA from the different MDA-MB-435 clones and Clone A colon carcinoma cells. As shown in Figure 1a , the a6b4 integrin-expressing MDA-MB-435 clones (MDA/b4, clones 5B3 and 3A7) display a 40-fold greater expression of autotaxin compared to the mock transfectants (MDA/mock, clones 6D2 and 6D7) and a four-fold greater level than a clone expressing the cytoplasmic deletion mutant of b4 integrin, which is deficient in signaling from the cytoplasmic tail (MDA/ b4Dcyt, clone 3C12). To confirm the expression of autotaxin at the protein level, we performed immunoblot analysis on conditioned medium and cell lysates of these cells. As shown in Figure 1b , autotaxin is more abundant in both the conditioned medium and cell lysates of the MDA/b4 clones compared with MDA/ mock and MDA/b4Dcyt clones. Notably, long-term culture of these MDA/b4 clones leads to loss of integrin b4 expression and concomitant loss of autotaxin expression (data not shown). Furthermore, we detected greater than a five-fold increase in PDE-I activity in the conditioned medium of the MDA/b4 cells, which is indicative of greater level of active autotaxin (Figure 1c) . Clone A is a colon adenocarcinoma cell line that expresses the a6b4 integrin and migrates on laminin in an a6b4 integrin-dependent manner . Here, we find that Clone A cells do not express autotaxin (Figure 1 ), thus suggesting that a6b4 integrin-dependent upregulation of autotaxin expression does not extend to colon carcinoma. These results demonstrate that expression of the a6b4 integrin in the MDA-MB-435 cells promotes the dramatic upregulation of autotaxin.
To determine if autotaxin secreted by the MDA-MB-435 cells functions as a chemoattractant, we collected conditioned medium from MDA/mock, MDA/b4 or MDA/b4Dcyt cells incubated 24 h in DMEM medium containing BSA (DMEM/BSA). MDA/mock or MDA/ b4 cells were then allowed to migrate in DMEM/BSA alone (BSA), or toward each of the conditioned media. As shown in Figure 2a , MDA/b4 conditioned medium gave a four-to six-fold greater rate of migration above the background migration in DMEM/BSA for both the MDA/mock and MDA/b4 transfectants when compared to migration toward MDA/mock or MDA/ Figure 1 Integrin a6b4 promotes the expression of autotaxin (ENPP2). (a) Total RNAs from MDA-MB-435 mock (MDA/ mock; clones 6D2, 6D7), b4 integrin (MDA/b4; clones 5B3, 3A7) or a b4 integrin cytoplasmic deletion mutant (MDA/b4Dcyt, clone 3C12) transfectants and Clone A colon carcinoma cells (from Arthur Mercurio, University of Massachusetts Medical School, Worchester, MA, USA) were cultured as described previously (O'Connor et al., 1998 (O'Connor et al., , 2000 . Q-PCR reactions to assess autotaxin expression were performed with 80 ng RNA for ENPP2 (autotaxin) and 18S RNA (endogenous control) using standard commercially available probes, reagents, and an ABI7000 sequence detector as described by the manufacturer (Applied Biosystems). The amount of autotaxin message was normalized to 18S RNA levels and reported as a relative value. (b) Conditioned medium (50 ml, top panel) collected from an equal number of cells incubated in serumfree, BSA (250 mg/ml) containing DMEM (breast cells) or RPMI (Clone A) overnight and the corresponding lysates (80 mg, middle panel) from cells lysed with RIPA buffer (150 mM NaCl, 0.5 mM EGTA, 0.1% DOC, 0.1% SDS, 1% Triton X-100, 50 mM TrisHCl, pH 7.4) were immunoblotted and probed for autotaxin (rabbit polyclonal antibody obtained from Drs Lance Liotta and Mary Stacke, National Cancer Institute, Bethesda, MD, USA). Cell lysate immunoblots were stripped and reprobed with mouse monoclonal antibodies against b-actin (1 : 15000; Sigma; bottom panel). rATX represents partially purified, virally produced recombinant autotaxin (from Dr Lance Liotta). (c) The 5 0 -nucleotide PDE activity of ATX in the conditioned medium was performed described previously (Clair et al., 1997) . Briefly, conditioned media (85 ml) from select cell lines or DMEM/BSA were incubated in a final volume of 100 ml containing 5 mM pnitrophenyl thymidine-5 0 -monophosphate (Sigma) and 50 mM TrisHCl (pH 8.9). After incubation at 371C for 4 h, reactions were terminated with 900 ml of 0.1 N NaOH. PDE type I activity was determined by quantifying reaction product absorbance at 410 nm, calculating nmoles of converted substrate (absorbance at OD 410 Â 64 ¼ nmol of p-nitrophenol) and adjusted for cell number. Bars (a, c) represent standard deviation of the mean from triplicate determinations. Representative experiments are shown from at least three separate experiments Integrin a6b4 control of autotaxin expression M Chen and KL O'Connor b4Dcyt conditioned medium. The b4 integrin subunit is suggested to signal predominantly through the cytoplasmic tail (Chao et al., 1996; Shaw et al., 1997) , and more specifically, through the C-terminal end that is not involved in hemidesmosmal binding (Nikolopoulos et al., 2004) . However, the b4 integrin cytoplasmic deletion mutant can still mediate a partial increase in autotaxin expression (Figure 1a, b) , suggesting that the transmembrane and extracellular domains may contribute to signaling from the b4 subunit.
To implicate the lyso-PLD activity of autotaxin as a source of the chemoattractant, we assessed MDA/b4 conditioned medium for chemotactic activity in the presence and absence of exogenous LPC, a lyso-PLD substrate. As shown in Figure 2b , we find that the addition of LPC to MDA/b4 conditioned medium enhanced the chemotactic activity of the conditioned medium, while LPC alone had no effect. Conditioned medium heated prior to adding LPC did not have activity while the conditioned medium incubated for 5 h with LPC prior to heating maintained its chemotactic activity. These data are consistent with previous reports (Tokumura et al., 2002; Umezu-Goto et al., 2002) showing that the lyso-PLD activity of autotaxin leads to the thermostabile production of LPA as a source of chemoattractant. Similar results were obtained with the MDA/b4Dcyt conditioned medium (data not shown). Finally, we show that reduction of autotaxin expression by siRNA reduces the chemotactic potential of the conditioned medium by 80% (Figure 2c ). Collectively, these data suggest that the enhanced autotaxin secretion by the MDA/b4 cells functions as the major chemoattractant in conditioned medium by converting LPC to LPA.
While autotaxin has been shown to be upregulated with advanced breast cancers, the mechanisms leading to its overexpression are not known. Our data show that Figure 2 Secreted autotaxin acts as a chemoattractant through the conversion of LPC to LPA. (a) To determine if secreted autotaxin functions as a chemoattractant, conditioned media from MDA/ mock (mock, clone 6D2), MDA/b4 (b4, clone 5B3) and MDA/ b4Dcyt (Dcyt, clone 3C12) were prepared from 70% confluent cultures incubated for 24 h in serum-free DMEM/BSA. Transwell chambers (6.5 mm-diameter, 8 mm pore size, Costar, Cambridge, MA, USA) were coated with 15 mg/ml collagen for 30 min at 371C. Conditioned medium (mock, b4, or b4Dcyt) or DMEM/BSA was added to the bottom chamber and MDA/mock and MDA/b4 cells (5 Â 10 4 ), as noted, were added to the top chamber and then incubated for 4 h at 371C. Chemotactic migration was then assessed as described previously (O'Connor et al., 1998) . (b) MDA/b4 cell conditioned medium (b4CM) or DMEM/BSA plus or minus 10 mM LPC (18 : 1; Sigma) was used as a chemoattractant for MDA/b4 clone 5B3 cell migration as done in panel A. As noted, MDA/b4 conditioned medium was also incubated with 10 mM LPC (18 : 1; Sigma) to facilitate the generation of LPA by autotaxin for 5 h at 371C before or after heating at 951C for 15 min. Bars represent standard deviation of the mean number of cells migrated per field (20 Â objective) from triplicate determinations. (c) To determine what portion of the motogenic activity of the MDA/b4 conditioned medium can be contributed to autotaxin expression, cells were left untreated (Untr) or treated cells with nonspecific (Non) or autotaxin siRNAs (Atx) siRNAs. After 48 h, conditioned medium was prepared and assessed for motogenic activity as done in (a). Values represent mean number of cells migrated minus background migration toward BSA and expressed relative to untreated cells. As shown, approximately 80% of migratory activity of the conditioned medium comes from autotaxin. Representative experiments are shown from at least three separate experiments Integrin a6b4 control of autotaxin expression M Chen and KL O'Connor the a6b4 integrin can promote autotaxin expression. The a6b4 integrin has also been shown to increase the expression and activity of NFAT1 and NFAT5 transcription factors in the MDA-MB-435 breast carcinoma cells, which is linked to the invasiveness of these cells (Jauliac et al., 2002) . The sequence of the autotaxin promoter has been reported previously (Kawagoe et al., 1997) . We find that the functional promoter region of autotaxin contains five NFAT consensus binding sites, which could be important for autotaxin transcription (determined using TRANSFAC v4.0 Transcription Factor Database (http://www.cbil.upenn.edu/cgi-bin/ tess) and MatInspector 7.0 (http://www.genomatix.de/ cgi-bin/matinspector) software). Furthermore, cell treatment with cyclosporin A to inhibit calcineurin, an upstream calcium-sensitive regulator of NFAT, downregulates autotaxin expression (data not shown). Accordingly, we electroporated MDA/b4 clones with either a control siRNA or with siRNAs designed to target NFAT1, NFAT5, autotaxin or the integrin b4 subunit (Dharmacon, Inc.). As shown in Figure 3 , siRNA targeting of NFAT1, but not NFAT5, resulted in a decrease in autotaxin expression as determined by Q-PCR ( Figure 3a ) and immunoblot analyses (Figure 3b) . The siRNA time course analysis reveals that NFAT1 siRNA downregulation of autotaxin message is delayed compared to the autotaxin siRNA. Notably, downregulation of b4 integrin expression also leads to a reduction in autotaxin expression; however, this reduction took substantially more time to accomplish than NFAT1 siRNA treatment. We suggest that this delay results from the need to downregulate NFAT1 expression before autotaxin expression can be affected. Therefore, based on the time needed for autotaxin downregulation using specific siRNAs and published data on the effect of the a6b4 integrin on NFAT, we suggest that the a6b4 integrin induces the expression and activation of NFAT1 that is required for b4 integrindependent upregulation of autotaxin as depicted in Figure 3c .
To further implicate NFAT1 in the a6b4 integrindependent upregulation of autotaxin, we looked at the ability of nuclear extracts of MDA/mock and MDA/b4 cells to bind oligonucleotides containing specific NFAT binding sequences using electrophoretic mobility shift assays. As shown in Figure 4 , MDA/b4 nuclear extracts more potently bind a commercially available NFAT probe ( Figure 4a ) and a NFAT site corresponding to À339 to À310 of the autotaxin promoter (Figure 4b) . Furthermore, we show that specific binding of this NFAT site of autotaxin is dependent on calcineurin, an upstream regulator of NFAT (Figure 4c) , and can be supershifted by NFAT1, but not NFAT5, antibodies (Figure 4d) . Similar results were found with a second NFAT site located at À1806 to À1780 (Figure 4e) . Together, these data firmly implicate NFAT1 as an important regulator of autotaxin expression downstream of the a6b4 integrin.
Our results demonstrate for the first time that autotaxin expression can be linked to signaling from the a6b4 integrin in breast carcinoma using the MDA-MB-435 cell model. Notably, the MDA-MB-435 cells are already reported to express relatively high levels of autotaxin (Yang et al., 2002) ; yet increasing expression, as seen in the a6b4 integrin expressing cells, yields a dramatically greater chemotactic potential (Figure 2a) . These data suggest that the ability of the a6b4 integrin to increase autotaxin expression could have dramatic biological implications. Interestingly, autotaxin is the second autocrine factor shown to be upregulated by the a6b4 integrin. The a6b4 integrin also promotes vascular endothelial growth factor secretion through HIF1a-mediated translational upregulation of VEGF protein . VEGF, through binding of neuropilin, has been shown to facilitate breast carcinoma invasion and survival (Bachelder et al., , 2003 . Like VEGF, autotaxin can also promote angiogenesis (Nam et al., 2001) , suggesting that it can play several roles in tumor progression. Together, autotaxin and VEGF could function downstream of the a6b4 integrin to promote the migration, invasion, survival and angiogenic response of breast carcinoma cells. The extent to which these factors may cooperate in tumorigenesis and metastasis, however, will require further investigation. Several studies on the function of the a6b4 integrin in carcinomas have reported that this integrin functions in a ligand-independent manner to promote a migratory and invasive phenotype (O'Connor et al., 1998; Gambaletta et al., 2000; Lipscomb et al., 2003) . This idea is based on the observations that the a6b4 integrin can promote invasion and migration on non-laminin substrata and that a6 and b4 integrin function blocking antibodies do not impede these processes during short-term in vitro experiments. We suspect that expression of the a6b4 integrin promotes an invasive and migratory phenotype due, in part, to its ability to promote the expression of promigratory factors such as autotaxin. Our data show that a6b4 integrin function must be blocked for several days before the expression of autotaxin can be down regulated (Figure 3 ). Therefore, it is possible that the a6b4 integrin does not actually function in a ligand independent manner; but rather, autocrine laminin secretion promotes ligation of the a6b4 integrin in culture that predisposes cells for an invasive phenotype through the generation of autocrine factors. Certainly, autocrine secretion of laminin 5 is known to correlate with the most aggressive carcinomas (Tani et al., 1997; Zahir et al., 2003) . While this idea is provocative, further experimental evidence will be needed to accurately define if the a6b4 integrin truly functions in a ligandindependent manner.
Our results highlight a previously unrecognized role for NFAT1 in the regulation of a promigratory and metastatic gene, namely autotaxin. NFAT1 is reported to be up regulated by signaling from the a6b4 integrin and is a critical mediator of integrin a6b4-induced cell invasion and migration (Jauliac et al., 2002 ); yet, how NFAT functions in the capacity is not known. NFAT is recognized as a potent regulator of cytokine production in leukocytes (Hogan et al., 2003) . While our gene chip and immunoblot analyses confirm NFAT overexpression in the MDA/b4 transfectants, we do not see increase gene expression of any cytokines (unpublished observation). Instead, we find that in the MDA-MB-435 Figure 4 NFAT sites in the autotaxin promoter specifically bind NFAT1. Electrophoretic mobility shift assays (EMSA) were performed on nuclear extracts from MDA/mock or MDA/b4 cells to determine NFAT activity as carried out previously (Tian et al., 1999) except probe and extracts were incubated in binding buffer containing 8% glycerol, 100 mM NaCl, 5 mM MgCl 2 5 mM DTT, 1 mM PMSF, 1 mg poly (dI-dC) and 40 000 cpm of [g-32 P]ATP labeled oligonucleotide probe on ice for 20 min. (a, b) The NFAT binding activity of nuclear extracts of MDA/mock (M) and MDA/b4 (b4) cells were compared using a commercially available NFAT probe (a; Santa Cruz Biotechnology) or a probe corresponding to site À339 to À310 (b, autotaxin NFAT site 2) of the autotaxin promoter (Black et al., 2004) . For (a), cells were pretreated with 100 nM PMA plus 1 mM ionomycin (P/I) for 30 min. prior to harvest and nuclear extracts were pretreated with 2 mg of NFAT1 antibody (N1 Ab; Sigma) 15 min prior to assaying for NFAT site binding, as noted. (c) MDA/b4 cells were left untreated or treated with 100 nM PMA plus 1 mM ionomycin (P/I) and/or 10 mM cyclosporin (CsA; an inhibitor of the NFAT activator calcineurin) for 30 min and then nuclear extracts were assessed for binding of the autotaxin NFAT site 2 probe from (b). (d) Nuclear extracts from PMA/ionomycin-treated MDA/b4 cells were incubated with 100-fold excess cold probe, 2 mg of NFAT1 or NFAT5 antibody, or an IgG control (Sigma) for 15 min prior to assaying for autotaxin NFAT site binding. (e) Binding activity of MDA/mock (M) and MDA/b4 (b4) cell nuclear extracts were assessed using an NFAT consensus site located at À1806 to À1780 of the autotaxin promoter (Atx site 4) as carried out in (a). Antibody (Ab) supershift, specific NFAT:probe complex (arrows), nonspecific binding and free probe bands are indicated. Representative experiments are shown Integrin a6b4 control of autotaxin expression M Chen and KL O'Connor cells, NFAT1, but not NFAT5, leads to an increase in autotaxin expression. Since autotaxin and its product LPA can both lead to the increased migration and survival of breast carcinoma cells, we suggest that NFAT may facilitates breast carcinoma progression, at least in part, due to its ability to facilitate autotaxin expression. Interestingly, Clone A colon carcinoma cells do not express NFAT1 (Jauliac et al., 2002) and do not expression autotaxin ( Figure 1) ; thus suggesting that NFAT transcription factors may contribute to the cell type specific expression of autocrine factors. In summary, this study highlights an important mechanism for how the a6b4 integrin-NFAT pathway can regulate autotaxin production and mediate breast carcinoma cell migration and invasion.
